3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Recruiting
1
Sponsor Class
OTHER
2
NIH
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Uterine Cervical Neoplasms
2
Rectal Neoplasms
2
Neoplasms
1
Benign Colorectal Neoplasm
1
Anastomotic Leak
1
Adenocarcinoma
1
Acquired Immunodeficiency Syndrome
1
Interventions
Oxaliplatin
180
Capecitabine
174
Fluorouracil
154
Radiotherapy
107
Leucovorin
107
Irinotecan
93
Bevacizumab
69
Surgical Procedures, Operative
49
Cetuximab
39
Drug Therapy
38
Radiation
35
Neoadjuvant Therapy
33
Folfox protocol
29
Chemoradiotherapy
29
XELOX
22
Magnetic Resonance Spectroscopy
21
Chemotherapy, Adjuvant
21
Radiotherapy, Intensity-Modulated
19
Surveys and Questionnaires
17
Proctectomy
16
Biopsy
16
Early Intervention, Educational
14
trifluridine tipiracil drug combination
12
Panitumumab
12
Floxuridine
12
tislelizumab
11
regorafenib
11
Nivolumab
11
Laparoscopy
11
Celecoxib
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Rectal Neoplasms
×
Proctoscopy
×
Clear all
NCT04927897
2025-07-28
DETECT
Maastricht Radiation Oncology
Recruiting
50 enrolled
NCT01887509
2018-05-15
TRaMA
IHU Strasbourg
Phase NA
Terminated
21 enrolled